Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort

Journal of Immunological Methods

Volumn 384, Issue 1-2, 2012, Pages 128-134

  Tarricone, Elena ^a   Ghirardello, Anna ^a   Rampudda, Mariaelisa ^a   Bassi, Nicola ^a   Punzi, Leonardo ^a   Doria, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anti SAE antibodies; Autoimmune myositis; Laboratory techniques; Myositis specific antibodies; Unlabelled protein immunoprecipitation

Indexed keywords

AUTOANTIBODY; HETERODIMER; MUSCLE ANTIBODY; MYOSITIS SPECIFIC ANTIBODY; SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC TEST ACCURACY STUDY; DYSPHAGIA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; ITALY; JUVENILE DERMATOMYOSITIS; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; MYOSITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMYOSITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCREENING; SILVER STAINING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNLABELLED PROTEIN IMMUNOPRECIPITATION;

ADOLESCENT; ADULT; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; ITALY; JURKAT CELLS; MIDDLE AGED; MYOSITIS; POLYMYOSITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84865609267     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.07.019     Document Type: Article

References (48)

1. Betteridge Z.E., Gunawardena H., Chinoy H., North J., Ollier W.E., Cooper R.G., McHugh N.J. Clinical and leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann. Rheum. Dis. 2009, 68:1621.
2. Betteridge Z.E., Gunawardena H., North J., Slinn J., McHugh N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum. 2007, 56:3132.
3. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 1975, 292:344.
4. Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 1975, 292:403.
5. Bons J.A., Michielsen E.C., de Boer D., Bouwman F.G., Jaeken J., van Dieijen-Visser M.P., Rubio-Gozalbo M.E., Wodzig W.K. A specific immunoprecipitation method for isolating isoforms of insulin-like growth factor binding protein-3 from serum. Clin. Chim. Acta 2008, 387:59.
6. Brandão M., Marinho A. Idiopathic inflammatory myopathies: definition and management of refractory disease. Autoimmun. Rev. 2011, 10:720.
7. Briani C., Doria A., Sarzi-Puttini P., Dalakas M.C. Update on idiopathic inflammatory myopathies. Autoimmunity 2006, 39:161.
8. Brouwer R., Hengstman G.J., Vree Egberts W., Ehrfeld H., Bozic B., Ghirardello A., Grøndal G., Hietarinta M., Isenberg D., Kalden J.R., Lundberg I., Moutsopoulos H., Roux-Lombard P., Vencovsky J., Wikman A., Seelig H.P., van Engelen B.G., van Venrooij W.J. Autoantibody profiles in the sera of European patients with myositis. Ann. Rheum. Dis. 2001, 60:116.
9. Chinoy H., Fertig N., Oddis C.V., Ollier W.E.R., Cooper R.G. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann. Rheum. Dis. 2007, 66:1345.
10. Dalakas M.C. Pathogenesis and therapies of immune-mediated myopathies. Autoimmun. Rev. 2012, 11(3):203.
11. Desterro J.M.P., Rodriguez M.S., Kemp G.D., Hay R.T. Identification of the enzyme required for activation of the Small Ubiquitin-like Protein SUMO-1. J. Biol. Chem. 1999, 274:10618.
12. Espada G., Maldonado Cocco J.A., Fertig N., Oddis C.V. Clinical and serological characterization of an argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J. Rheumatol. 2009, 36:2547.
13. Ghirardello A., Rampudda M., Ekholm L., Bassi N., Tarricone E., Zampieri S., Zen M., Vattemi G.A., Lundberg I.E., Doria A. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 2010, 49:2370.
14. Ghirardello A., Zampieri S., Iaccarino L., Tarricone E., Bendo R., Gambari P.F., Doria A. Anti-Mi-2 antibodies. Autoimmunity 2005, 38:79.
15. Ghirardello A., Zampieri S., Iaccarino L., Tarricone E., Tonello M., Bendo R., Rondinone R., Cozzi F., Doria A. Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients. Reumatismo 2005, 57:22.
16. Ghirardello A., Zampieri S., Tarricone E., Iaccarino L., Bendo R., Briani C., Rondinone R., Sarzi-Puttini P., Todesco S., Doria A. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006, 39:217.
17. Ghirardello A., Zampieri S., Tarricone E., Iaccarino L., Gorza L., Doria A. Cutting edge issues in polymyositis. Clin. Rev. Allergy Immunol. 2011, 41:179.
18. Gong Z., Brackertz M., Renkawitz R. SUMO modification enhances p66-mediated trascriptional repression of the Mi-2/NuRD complex. Mol. Cell. Biol. 2006, 26:4519.
19. Gunawardena H., Betteridge Z.E., McHugh N.J. Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr. Opin. Rheumatol. 2008, 20:675.
20. Gunawardena H., Betteridge Z.E., McHugh N.J. Myositis specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 2009, 48:607.
21. Gunawardena H., Wedderburn L.R., Chinoy H., Betteridge Z.E., North J., Ollier W.E., Cooper R.G., Oddis C.V., Ramanan A.V., Davidson J.E., McHugh N.J. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 2009, 60:1807.
22. Gunawardena H., Wedderburn L.R., North J., Betteridge Z., Dunphy J., Chinoy H., Davidson J.E., Cooper R.G., McHugh N.J. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology 2008, 47:324.
23. Guseinova D., Consolaro A., Trail L., Ferrari C., Pistorio A., Ruperto N., Buoncompagni A., Pilkington C., Maillard S., Oliveira S.K., Sztajnbok F., Cuttica R., Corona F., Katsicas M.M., Russo R., Ferriani V., Burgos-Vargas R., Solis-Vallejo E., Bandiera M., Baca V., Saad-Magalhaes C., Silva C.A., Barcellona R., Breda L., Cimaz R., Gallizzi R., Garozzo R., Martino S., Meini A., Stabile A., Martini A., Ravelli A. Comparison of clinical features and drug therapy among European and Latin American patients with juvenile dermatomyositis. Clin. Exp. Rheumatol. 2011, 29:117.
24. Hengstman G.J., ter Laak H.J., Vree Egberts W.T., Lundberg I.E., Moutsopoulos H.M., Vencovsky J., Doria A., Mosca M., van Venrooij W.J., van Engelen B.G. Anti-signal recognition particle autoantibodies: marker of necrotising myopathy. Ann. Rheum. Dis. 2006, 65:1635.
25. Hengstman G.J., Vree Egberts W.T., Seeling H.P., Lundberg I.E., Moutsopoulos H.M., Doria A., Mosca M., Vencovsky J., van Venrooij W.J., van Engelen B.G. Clinical Characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann. Rheum. Dis. 2006, 65:242.
26. Henriques-Pons A., Nagaraju K. Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr. Opin. Rheumatol. 2009, 21:581.
27. Kaji K., Fujimoto M., Hasegawa M., Kondo M., Saito Y., Komura K., Matsushita T., Orito H., Hamaguchi Y., Yanaba K., Itoh M., Asano Y., Seishima M., Ogawa F., Sato S., Takehara K. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 2007, 46:25.
28. Kimura Y., Sakai F., Nakano O., Kisaki O., Sugimoto H., Sawamura T., Sadano H., Osumi T. The newly identified Human Nuclear Protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains. J. Biol. Chem. 2002, 277:20611.
29. Mammen A.L. Dermatomyositis and polymyositis. Clinical presentation, autoantibodies, and pathogenesis. Ann. N. Y. Acad. Sci. 2010, 1184:134.
30. Marco Puche A., Calvo Penades I., Lopez Montesinos B. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin. Exp. Rheumatol. 2010, 28:135.
31. Mathiesen P.R., Zak M., Herlin T., Nielsen S.M. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin. Exp. Rheumatol. 2010, 28:782.
32. Nagaraju K., Casciola-Rosen L., Lundberg I., Rawat R., Cutting S., Thapliyal R., Chang J., Dwivedi S., Mitsak M., Chen Y.W., Plotz P., Rosen A., Hoffman E., Raben N. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005, 52:1824.
33. Nakashima R., Imura Y., Kobayashi S., Yukawa N., Yoshifuji H., Nojima T., Kawabata D., Ohmura K., Usui T., Fujii T., Okawa K., Mimori T. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2010, 49:433.
34. Salviati G., Betto R., Danieli Betto D. Polymorphism of myofibrillar proteins of rabbit skeletal-muscle fibres. An electrophoretic study of single fibres. Biochem. J. 1982, 207:261.
35. Sarge K.D., Park-Sarge O.K. Sumoylation and human disease pathogenesis. Trends Biochem. Sci. 2009, 34:200.
36. Sato S., Hirakata M., Kuwana M., Suwa A., Inada S., Mimori T., Nishikawa T., Oddis C.V., Ikeda Y. Autoantibodies to a 140-kd Polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52:1571.
37. Sato S., Hoshino K., Satoh T., Fujita T., Kawakami Y., Fujita T., Kuwana M. RNA helicase encoded by Melanoma Differentiation-Associated Gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2009, 60:2193.
38. Tan E.M., Peebles C.L. Immunoprecipitation of labelled proteins. Manual of biological markers of disease 1993, Kluwer Academic Publishers, London, (section A, chapter 6). W.J. Van Venrooij, R.N. Maini (Eds.).
39. Targoff I.N., Mamyrova G., Trieu E.P., Perurena O., Koneru B., O'Hanlon T.P., Miller F.W., Rider L.G. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006, 54:3682.
40. Trieu E.P., Gross J.K., Targoff I.N. Immunoprecipitation-western blot for proteins of low abundance. Protein Blotting and Detection 2009, vol. 536:259. Humana Press, Oklahoma City. B.T. Kurien, R.H. Scofield (Eds.).
41. Vattemi G., King Engel W., McFerrin J., Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am. J. Pathol. 2004, 164:1.
42. Vitadello M., Doria A., Tarricone E., Ghirardello A., Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res. Ther. 2010, 12:R52.
43. Wilkinson K.A., Henley J.M. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 2010, 482:133.
44. Yan K.P., Dollé P., Mark M., Lerouge T., Wendling O., Chambon P., Losson R. Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene. Gene 2004, 334:3.
45. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Michael Gale J., Akira S., Yonehara S., Kato A., Fujita T. Shared and unique functions of the DExD/H-Box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 2010, 175:2851.
46. Zampieri S., Ghirardello A., Iaccarino L., Briani C., Sarzi-Puttini P., Atzeni F., Arienti S., Todesco S., Doria A. Polymyositis-dermatomyositis and infection. Autoimmunity 2006, 39:191.
47. Zampieri S., Ghirardello A., Iaccarino L., Tarricone E., Gambari P.F., Doria A. Anti-Jo-1 antibodies. Autoimmunity 2005, 38:73.
48. Zampieri S., Ghirardello A., Rossini K., Iaccarino L., Bassi N., Atzeni F., Sarzi-Puttini P., Doria A. Antigen preparation for immunological studies in systemic autoimmune diseases. Ann. N. Y. Acad. Sci. 2007, 1109:193.